HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao Wu Selected Research

Xue-Fu-Zhu-Yu decoction

7/2022Systematic analysis of tRNA-derived small RNAs reveals therapeutic targets of Xuefu Zhuyu decoction in the cortexes of experimental traumatic brain injury.
1/2022Bioinformatics Analysis of miRNAs and mRNAs Network-Xuefu Zhuyu Decoction Exerts Neuroprotection of Traumatic Brain Injury Mice in the Subacute Phase.
1/2020Metabolomics Deciphers Potential Targets of Xuefu Zhuyu Decoction Against Traumatic Brain Injury in Rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao Wu Research Topics

Disease

51Neoplasms (Cancer)
11/2022 - 06/2009
15Sepsis (Septicemia)
01/2022 - 06/2007
10Inflammation (Inflammations)
04/2022 - 09/2015
10Neoplasm Metastasis (Metastasis)
01/2022 - 01/2015
9Infections
01/2022 - 01/2016
7Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2014
6Carcinogenesis
11/2021 - 11/2013
6Ovarian Neoplasms (Ovarian Cancer)
07/2020 - 02/2015
5Fibrosis (Cirrhosis)
04/2022 - 01/2018
5Circulating Neoplastic Cells
01/2022 - 04/2018
5Atherosclerosis
12/2021 - 09/2015
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2018
5Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2012
4Traumatic Brain Injuries (Traumatic Brain Injury)
07/2022 - 01/2020
4Congenital Heart Defects (Congenital Heart Defect)
06/2022 - 09/2013
4Hypertrophy
04/2022 - 12/2016
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2017
4Pathologic Processes
11/2021 - 08/2009
4Carcinoma (Carcinomatosis)
01/2020 - 06/2009
3Glioma (Gliomas)
09/2022 - 10/2017
3Cardiomegaly (Heart Hypertrophy)
04/2022 - 01/2018
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2012
3Virus Diseases (Viral Diseases)
01/2022 - 01/2016
3Cardiotoxicity
10/2021 - 12/2016
3Hypertension (High Blood Pressure)
12/2019 - 09/2018
3Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
01/2019 - 11/2017
3Heart Failure
10/2018 - 01/2017
3Cholangiocarcinoma
09/2018 - 07/2015
3Hypoxia (Hypoxemia)
01/2018 - 01/2014
3Colonic Neoplasms (Colon Cancer)
10/2016 - 10/2013
3Tetralogy of Fallot (Fallot Tetralogy)
05/2014 - 05/2012
2Hemangioma (Angioma)
12/2021 - 01/2020
2Renal Insufficiency (Renal Failure)
12/2021 - 01/2021
2Gout
01/2021 - 10/2020
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2021
2Osteoporosis
12/2020 - 04/2020
2Hypoglycemia (Reactive Hypoglycemia)
12/2020 - 10/2020
2Hyperlipidemias (Hyperlipidemia)
10/2020 - 05/2020
2Cardiomyopathies (Cardiomyopathy)
10/2020 - 07/2018
2Pneumonia (Pneumonitis)
01/2020 - 12/2019
2Ischemic Stroke
12/2019 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2019 - 03/2015

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2012
11MicroRNAs (MicroRNA)IBA
05/2022 - 09/2013
8Biological ProductsIBA
01/2022 - 09/2015
8Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2020
8Particulate MatterIBA
07/2021 - 10/2018
7DNA (Deoxyribonucleic Acid)IBA
11/2022 - 05/2012
7Pharmaceutical PreparationsIBA
01/2022 - 12/2009
6Transcription Factors (Transcription Factor)IBA
01/2018 - 10/2013
5Apolipoproteins E (ApoE)IBA
12/2021 - 09/2015
5CytokinesIBA
12/2020 - 07/2012
4acacetinIBA
04/2022 - 01/2018
4Messenger RNA (mRNA)IBA
01/2022 - 06/2007
4ApolipoproteinsIBA
12/2021 - 09/2015
4PhosphopeptidesIBA
11/2021 - 01/2020
4Doxorubicin (Adriamycin)FDA LinkGeneric
10/2021 - 12/2009
4antineoplaston A10 (A 10)IBA
02/2021 - 01/2019
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 08/2015
4HMGB1 Protein (HMG1)IBA
01/2021 - 07/2012
4Fluorouracil (Carac)FDA LinkGeneric
05/2017 - 11/2013
3Xue-Fu-Zhu-Yu decoctionIBA
07/2022 - 01/2020
3flavoneIBA
04/2022 - 01/2018
3Angiotensin IIIBA
04/2022 - 01/2018
3GlycopeptidesIBA
01/2022 - 01/2021
3Protein CoronaIBA
01/2022 - 01/2014
3LigandsIBA
01/2022 - 08/2009
3AntioxidantsIBA
10/2021 - 03/2016
3CateninsIBA
08/2021 - 10/2018
3CholesterolIBA
01/2021 - 01/2012
3LipidsIBA
01/2020 - 05/2018
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 10/2017
3Cisplatin (Platino)FDA LinkGeneric
07/2017 - 07/2015
2Chemokine ReceptorsIBA
09/2022 - 01/2020
2Hydrocortisone (Cortisol)FDA LinkGeneric
06/2022 - 12/2020
2Sirtuin 1IBA
04/2022 - 10/2020
2AntigensIBA
01/2022 - 01/2021
2EstersIBA
12/2021 - 08/2018
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2021 - 06/2009
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2021 - 06/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 08/2007
2AcidsIBA
02/2021 - 08/2018
2Epithelial Cell Adhesion MoleculeIBA
01/2021 - 04/2018
2CalciumIBA
12/2020 - 01/2020
2Insulin (Novolin)FDA Link
12/2020 - 09/2020
2TabletsIBA
12/2020 - 12/2015
2CollagenIBA
07/2020 - 10/2017
2LuciferasesIBA
07/2020 - 03/2016
2sepiapterin reductaseIBA
01/2020 - 01/2020
2Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2019 - 10/2017

Therapy/Procedure

13Therapeutics
05/2022 - 11/2013
6Drug Therapy (Chemotherapy)
01/2021 - 10/2013
5Punctures
01/2022 - 08/2007
5Ligation
01/2022 - 08/2007
3Length of Stay
03/2021 - 09/2020
3Radiotherapy
01/2021 - 10/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
07/2022 - 08/2007
2Immunotherapy
04/2022 - 01/2022
2Oral Administration
12/2019 - 01/2019
2Radiofrequency Ablation
08/2019 - 01/2019